Prognosis
Lack of Progress in Treating Covid Causes Worry for Unvaccinated
- Advances to treatment stalled in last year despite early gains
- Plateau risks more deaths among unvaccinated U.S. population
Dexamethasone, proven effective at reducing deaths for Covid-19 patients on ventilators is now used around the world.
Photographer: Matthew Horwood/Getty Images
This article is for subscribers only.
A stall in treatment advances for Covid-19 has raised concern among medical experts about unvaccinated people, who still make up half the country, and their likelihood of surviving the coming wave of delta cases.
Though fewer people have died during the recent spike than earlier in the pandemic, that’s largely because many older people who are vulnerable to developing severe Covid-19 have been vaccinated.